Sponsors

Next-generation DNA sequencing platform

Applied Biosystems has announced the worldwide commercial availability of the SOLiD system, the companyÆs nextgeneration DNA sequencing platform.

The SOLiD system is already enabling new ways of performing genetic analysis applications, which may set new standards for how scientists are able to approach complex challenges associated with understanding the biological basis for health and disease.

This new era of life-science research calls for technologies that can help scientists identify how genetic variation and patterns of gene expression contribute to disease, the manner in which individual genotypes impact, and how people may respond to various treatments. The SOLiD system is distinguished by unparallelled throughput, scalability, accuracy and application flexibility.

Applied Biosystems www.appliedbiosystems.com

Latest Issues

Pathology Visions 24

Hyatt Regency, Orlando, FL
3-5 November, 2025

UK NEQAS Cellular Pathology Technique - Annual Participant’s Meeting

America Square Conference Centre, London, EC3N 2LB.
4 - 5 November, 2024

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024